Literature DB >> 29627827

Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.

Zhengwei Leng1, Qinghua Xia2, Jinhuang Chen2, Yong Li2, Jiqian Xu2, Ende Zhao2, Hai Zheng2, Walden Ai3, Jiangchuan Dong4.   

Abstract

BACKGROUND/AIMS: Although EpCAM+CD44+ cells exhibit more stem-like properties than did EpCAM-CD44- cells, the specificity of EpCAM combined with CD44 in defining CSCs needs further improvement. Lgr5 is used as a biomarker to isolate cancer stem cells (CSCs) in colorectal cancer. However, it remains unclear whether Lgr5, along with EpCAM and CD44, can further identify and define CSCs in colorectal cancer.
METHODS: Lgr5+CD44+EpCAM+, Lgr5+CD44+EpCAM-, Lgr5+CD44-EpCAM+, Lgr5-CD44+EpCAM+, and Lgr5-CD44-EpCAM-cells were separately isolated using fluorescence-activated cell sorting (FACS). Colony formation, self-renewal, differentiation, and tumorigenic properties of these cells were investigated through in vitro experiments and in vivo tumor xenograft models. The expression of stemness genes and CSC- and epithelial-mesenchymal transition (EMT)-related genes, such as KLF4, Oct4, Sox2, Nanog, CD133, CD44, CD166, ALDH1, Lgr5, E-cadherin, ZO-1, Vimentin, Snail, Slug, and Twist, was examined using real-time PCR.
RESULTS: Lgr5-positive subpopulations exhibited higher capacities for colony formation, self-renewal, differentiation, and tumorigenicity as well as higher expression of stemness genes and mesenchymal genes and lower expression of epithelial genes than did Lgr5-negative subpopulations.
CONCLUSION: Our data revealed that tumorigenic cells were highly restricted to Lgr5-positive subpopulations. Most importantly, Lgr5+CD44+EpCAM+ cells exhibited more pronounced CSC-like traits than did any other subpopulation, indicating that Lgr5 combined with CD44 and EpCAM can further improve the stem-like traits of CSCs in colorectal cancer.
© 2018 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Biomarkers; CD44; Cancer stem cells; Colorectal cancer; EpCAM; Epithelial-mesenchymal transition; Lgr5

Mesh:

Substances:

Year:  2018        PMID: 29627827     DOI: 10.1159/000488743

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  20 in total

1.  RUNX2 interacts with BRG1 to target CD44 for promoting invasion and migration of colorectal cancer cells.

Authors:  Xiaodong Yan; Dali Han; Zhiqiang Chen; Chao Han; Wei Dong; Li Han; Lei Zou; Jianbo Zhang; Yan Liu; Jie Chai
Journal:  Cancer Cell Int       Date:  2020-10-15       Impact factor: 5.722

Review 2.  The shifting paradigm of colorectal cancer treatment: a look into emerging cancer stem cell-directed therapeutics to lead the charge toward complete remission.

Authors:  Jessica Kopenhaver; Madison Crutcher; Scott A Waldman; Adam E Snook
Journal:  Expert Opin Biol Ther       Date:  2021-05-24       Impact factor: 5.589

3.  Clinicopathological Significance of Tumor Stem Cell Markers ALDH1 and CD133 in Colorectal Carcinoma.

Authors:  Maryam Rezaee; Elmira Gheytanchi; Zahra Madjd; Mitra Mehrazma
Journal:  Iran J Pathol       Date:  2020-10-10

Review 4.  CD44 as a tumor biomarker and therapeutic target.

Authors:  Hanxiao Xu; Mengke Niu; Xun Yuan; Kongming Wu; Aiguo Liu
Journal:  Exp Hematol Oncol       Date:  2020-12-10

Review 5.  Regulation of Hedgehog Signaling by miRNAs and Nanoformulations: A Possible Therapeutic Solution for Colorectal Cancer.

Authors:  Zeeshan Javed; Muhammad Javed Iqbal; Amna Rasheed; Haleema Sadia; Shahid Raza; Asma Irshad; Wojciech Koch; Wirginia Kukula-Koch; Anna Głowniak-Lipa; William C Cho; Javad Sharifi-Rad
Journal:  Front Oncol       Date:  2021-01-07       Impact factor: 6.244

6.  A radiosensitizer, gallotannin-rich extract from Bouea macrophylla seeds, inhibits radiation-induced epithelial-mesenchymal transition in breast cancer cells.

Authors:  Jiraporn Kantapan; Siwaphon Paksee; Aphidet Duangya; Padchanee Sangthong; Sittiruk Roytrakul; Sucheewin Krobthong; Wipob Suttana; Nathupakorn Dechsupa
Journal:  BMC Complement Med Ther       Date:  2021-07-03

Review 7.  Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.

Authors:  Lia Walcher; Ann-Kathrin Kistenmacher; Huizhen Suo; Reni Kitte; Sarah Dluczek; Alexander Strauß; André-René Blaudszun; Tetyana Yevsa; Stephan Fricke; Uta Kossatz-Boehlert
Journal:  Front Immunol       Date:  2020-08-07       Impact factor: 7.561

8.  Krüppel-like factor 4 regulates stemness and mesenchymal properties of colorectal cancer stem cells through the TGF-β1/Smad/snail pathway.

Authors:  Zhengwei Leng; Yong Li; Guojun Zhou; Xiaojiang Lv; Walden Ai; Jianshui Li; Lingmi Hou
Journal:  J Cell Mol Med       Date:  2019-12-12       Impact factor: 5.310

Review 9.  A Shifty Target: Tumor-Initiating Cells and Their Metabolism.

Authors:  Nicole Bezuidenhout; Maria Shoshan
Journal:  Int J Mol Sci       Date:  2019-10-28       Impact factor: 5.923

10.  Isolation and Characterization of Two Novel Colorectal Cancer Cell Lines, Containing a Subpopulation with Potential Stem-Like Properties: Treatment Options by MYC/NMYC Inhibition.

Authors:  Jan Schulte Am Schulte Am Esch; Beatrice Ariane Windmöller; Johannes Hanewinkel; Jonathan Storm; Christine Förster; Ludwig Wilkens; Martin Krüger; Barbara Kaltschmidt; Christian Kaltschmidt
Journal:  Cancers (Basel)       Date:  2020-09-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.